Current advances in chitosan nanoparticles based oral drug delivery for colorectal cancer treatment

H Choukaife, S Seyam, B Alallam… - International journal …, 2022 - Taylor & Francis
As per the WHO, colorectal cancer (CRC) caused around 935,173 deaths worldwide in 2020
in both sexes and at all ages. The available anticancer therapies including chemotherapy …

The gut microbiome, microsatellite status and the response to immunotherapy in colorectal cancer

TO Sillo, AD Beggs, G Middleton… - International Journal of …, 2023 - mdpi.com
There is increasing evidence in a range of cancer types that the microbiome plays a direct
role in modulating the anti-cancer immune response both at the gut level and systemically …

Long-term outcomes of robot-assisted versus laparoscopic surgery for colon cancer: a nationwide register-based cohort study

P Cuk, L Kaalby, U Deding, I Al-Najami… - Annals of …, 2024 - journals.lww.com
Objective: To determine long-term survival in patients undergoing robot-assisted surgery
(RAS) or laparoscopic surgery (LAS) for colon cancer. Background: The potential long-term …

Lymph node metastasis in T1-2 colorectal cancer: a population-based study

X Xiong, C Wang, J Cao, Z Gao, Y Ye - International Journal of Colorectal …, 2023 - Springer
Background We performed this study to identify predictive factors for lymph node metastasis
(LNM) and analyze the impact of LNM on the prognosis of patients with T1-2 colorectal …

Prognostic relevance of primary tumor sidedness in early-stage colorectal cancer: an integrated analysis of 4 randomized controlled trials (JCOG2003A)

A Ouchi, RYO Sadachi, T Hamaguchi… - Annals of …, 2024 - journals.lww.com
Objective: The aim of this study was to determine the genuine prognostic relevance of
primary tumor sidedness (PTS) in patients with early-stage colorectal cancer (CRC) …

Prognostic factors and survival disparities in right-sided versus left-sided colon cancer

M Asghari-Jafarabadi, S Wilkins, JP Plazzer, R Yap… - Scientific Reports, 2024 - nature.com
Right-sided colon cancer (RCC) and left-sided colon cancer (LCC) differ in features and
outcomes because of variations in embryology, epidemiology, pathology, and prognosis …

Do differences in surgical quality account for the higher rate of R1 margins to lymph node metastases in right‐versus left‐sided Stage III colon cancer: A retrospective …

HG Smith, DJ Chiranth, NH Schlesinger - Colorectal Disease, 2023 - Wiley Online Library
Aim Microscopically positive (R1) margins to lymph node metastases (R1LNM) are
associated with poorer oncological outcomes in patients with Stage III colon cancer. R1LNM …

Integrated decision-making in the treatment of colon-rectal cancer: the case of KRAS-mutated tumors

S Cherri, L Melocchi, L Gandolfi, G Rossi, A Zaniboni - Life, 2023 - mdpi.com
In recent years, precision medicine has taken an increasing place in various branches of
medical oncology, including colorectal cancer. Among the potentially relevant mutations for …

Prognostic impact of tumor budding in rectal cancer after neoadjuvant therapy: a systematic review and meta-analysis

J Li, Y Ma, L Wen, G Zhang, C Huang, J Wang… - Systematic Reviews, 2024 - Springer
Background Tumor budding (TB) is a negative prognostic factor in colorectal cancer;
however, its prognostic impact following neoadjuvant therapy for patients with rectal cancer …

[HTML][HTML] The Significance of C-Reactive Protein Value and Tumor Grading for Malignant Tumors: A Systematic Review

P Șiancu, GC Oprinca, AC Vulcu, M Pătran… - Diagnostics, 2024 - mdpi.com
The Significance of C-Reactive Protein Value and Tumor Grading for Malignant Tumors: A
Systematic Review Next Article in Journal Estimating the Extraction Time of an Upper Third …